Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

CGRP migraine drugs need prior approval for use, recommends ICER

CGRP migraine drugs need prior approval for use, recommends ICER

that it offered value for money, but only if other migraine prevention options such as Allergan’s Botox and anti-epilepsy drugs such as topiramate had been exhausted.

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line That includes drugs such as Allergan’s Botox, which costs around $3, 500 per year, as well as certain anti-epilepsy drugs such as topiramate.

Novartis, Amgen set low price for first CGRP migraine drug

Novartis, Amgen set low price for first CGRP migraine drug medicines such as the anticonvulsant topiramate or Allergan's Botox. ... As a migraine treatment Botox costs around $3, 500 per year, and analysts predict that the annual price for Aimovig will drop to around $5, 000 with rebates and discounts.

Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more

Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more Despite this embarrassing failure, yesterday’s Q1 results were encouraging, with revenues up 2.8% thanks to growth in Botox, Vraylar and regenerative medicines.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics